{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:07:15Z","timestamp":1777590435587,"version":"3.51.4"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>Os objetivos principais do tratamento da tuberculose s\u00e3o curar o paciente e minimizar a possibilidade de transmiss\u00e3o do bacilo para indiv\u00edduos saud\u00e1veis. Rea\u00e7\u00f5es adversas ou intera\u00e7\u00f5es das drogas antituberculose entre si e com outros f\u00e1rmacos podem causar modifica\u00e7\u00e3o ou descontinua\u00e7\u00e3o da terap\u00eautica. Descrevemos os mecanismos gerais de a\u00e7\u00e3o, absor\u00e7\u00e3o, metaboliza\u00e7\u00e3o e excre\u00e7\u00e3o dos medicamentos utilizados no tratamento da tuberculose multidroga resistente (aminoglicos\u00eddeos, fluoroquinolonas, cicloserina\/terizidona, etionamida, capreomicina e \u00e1cido para-aminossalic\u00edlico). Descrevemos as rea\u00e7\u00f5es adversas e as intera\u00e7\u00f5es (com medicamentos, alimentos e anti\u00e1cidos) assim como a abordagem mais adequada para situa\u00e7\u00f5es especiais, como gravidez, amamenta\u00e7\u00e3o, insufici\u00eancia hep\u00e1tica e renal.<\/jats:p>","DOI":"10.1590\/s1806-37132010000500017","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T02:18:28Z","timestamp":1289614708000},"page":"641-656","source":"Crossref","is-referenced-by-count":61,"title":["Drogas antituberculose: intera\u00e7\u00f5es medicamentosas, efeitos adversos e utiliza\u00e7\u00e3o em situa\u00e7\u00f5es especiais - parte 2: f\u00e1rmacos de segunda linha"],"prefix":"10.1590","volume":"36","author":[{"given":"Marcos Abdo","family":"Arbex","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Secretaria de Estado da Sa\u00fade do Estado de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia de Castro Lima","family":"Varella","sequence":"additional","affiliation":[{"name":"Universidade de Mogi das Cruzes, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio Ribeiro de","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto Fi\u00faza de","family":"Mello","sequence":"additional","affiliation":[{"name":"Secretaria de Estado da Sa\u00fade do Estado de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Nota t\u00e9cnica sobre as mudan\u00e7as no tratamento da tuberculose no Brasil para adultos e adolescentes: vers\u00e3o 2","year":"2009"},{"key":"ref2","series-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: Emergency Update 2008","year":"2008"},{"issue":"10","key":"ref3","first-page":"1018","article-title":"III Brazilian Thoracic Association Guidelines on tuberculosis","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"issue":"4582","key":"ref4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.2.4582.769","article-title":"STREPTOMYCIN treatment of pulmonary tuberculosis","volume":"2","year":"1948","journal-title":"Br Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.pharmtox.45.120403.100120","article-title":"The magic bullets and tuberculosis drug targets","volume":"45","author":"Zhang Y","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol","ISSN":"https:\/\/id.crossref.org\/issn\/0362-1642","issn-type":"print"},{"key":"ref6","series-title":"Intervenciones para el control y la eliminaci\u00f3n de la tuberculosis","first-page":"32","author":"Rieder HL","year":"2007"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.idc.2009.06.004","article-title":"Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides","volume":"23","author":"Chen LF","year":"2009","journal-title":"Infect Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5520","issn-type":"print"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.eimc.2009.06.010","article-title":"Active drugs against Mycobacterium tuberculosis","volume":"27","author":"Coll P","year":"2009","journal-title":"Enferm Infecc Microbiol Clin","ISSN":"https:\/\/id.crossref.org\/issn\/0213-005X","issn-type":"print"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy S","year":"1998","journal-title":"Tuber Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0962-8479","issn-type":"print"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg HM","year":"2003","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref11","series-title":"The Treatment of Tuberculosis Guidelines","year":"2010"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin CA","year":"2004","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"2-3","key":"ref13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie OW","year":"2008","journal-title":"Toxicology","ISSN":"https:\/\/id.crossref.org\/issn\/0300-483X","issn-type":"print"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak MJ","year":"1999","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.47.3.1010-1016.2003","article-title":"Aminoglycoside nephrotoxicity: modeling, simulation, and control","volume":"47","author":"Rougier F","year":"2003","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"7","key":"ref16","first-page":"622","article-title":"Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis","volume":"6","author":"de Jager P","year":"2002","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.mcna.2006.06.008","article-title":"Antibiotic drug interactions","volume":"90","author":"Pai MP","year":"2006","journal-title":"Med Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7125","issn-type":"print"},{"key":"ref18","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"359","volume-title":"Aminoglycosides","author":"Gilbert DN","year":"2009"},{"issue":"3","key":"ref19","first-page":"352","article-title":"Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis","volume":"131","author":"Tsukamura M","year":"1985","journal-title":"Am Rev Respir Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0003-0805","issn-type":"print"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","article-title":"Fluoroquinolones, tuberculosis, and resistance","volume":"3","author":"Ginsburg AS","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/dkh377","article-title":"Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?","volume":"54","author":"Di Perri G","year":"2004","journal-title":"J Antimicrob Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0305-7453","issn-type":"print"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"van den Boogaard J","year":"2009","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1378\/chest.124.4.1476","article-title":"Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong","volume":"124","author":"Yew WW","year":"2003","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick CD","year":"2008","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.200308-1159OC","article-title":"Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis","volume":"169","author":"Chan ED","year":"2004","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S1472-9792(08)70037-4","article-title":"Pharmacokinetics and pharmacodynamics in the development of antituberculosis drugs","volume":"88","author":"Davies GR","year":"2008","journal-title":"Tuberculosis"},{"issue":"1","key":"ref27","first-page":"CD004795","article-title":"Fluoroquinolones for treating tuberculosis","author":"Ziganshina LE","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"ref28","first-page":"1215","article-title":"Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia","volume":"9","author":"Yoon YS","year":"2005","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.200901-0146OC","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure","volume":"180","author":"Devasia RA","year":"2009","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.00104209","article-title":"Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?","volume":"35","author":"Chang KC","year":"2010","journal-title":"Eur Respir J","ISSN":"https:\/\/id.crossref.org\/issn\/0903-1936","issn-type":"print"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0025-7125(16)30044-X","article-title":"Quinolones","volume":"79","author":"Suh B","year":"1995","journal-title":"Med Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7125","issn-type":"print"},{"issue":"2","key":"ref32","first-page":"119","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"2","key":"ref33","first-page":"127","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0891-5520(05)70260-9","article-title":"Fluoroquinolones","volume":"14","author":"O'Donnell JA","year":"2000","journal-title":"Infect Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5520","issn-type":"print"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones: focus on respiratory infections","volume":"62","author":"Zhanel GG","year":"2002","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2009.06.003","article-title":"The newer fluoroquinolones","volume":"23","author":"Bolon MK","year":"2009","journal-title":"Infect Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5520","issn-type":"print"},{"issue":"5A","key":"ref37","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/0002-9343(89)90021-1","article-title":"Pharmacokinetics of three newer quinolones in pregnant and lactating women","volume":"87","author":"Giamarellou H","year":"1989","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically significant interactions with drugs used in the treatment of tuberculosis","volume":"25","author":"Yew WW","year":"2002","journal-title":"Drug Saf","ISSN":"https:\/\/id.crossref.org\/issn\/0114-5916","issn-type":"print"},{"key":"ref39","series-title":"Normas para o diagn\u00f3stico, tratamento, isolamento e preven\u00e7\u00e3o da tuberculose","year":"2009"},{"issue":"11","key":"ref40","first-page":"1320","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis","volume":"13","author":"Zhang Y","year":"2009","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"2","key":"ref41","first-page":"100","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"key":"ref42","series-title":"Tuberculose Multirresistente: Guia de Vigil\u00e2ncia Epidemiol\u00f3gica","year":"2007"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5520(03)00047-3","article-title":"Multidrug-resistant tuberculosis","volume":"16","author":"Seaworth BJ","year":"2002","journal-title":"Infect Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5520","issn-type":"print"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.116.4.984","article-title":"The effect of hemodialysis on cycloserine, ethionamide, para-aminosalicylate, and clofazimine","volume":"116","author":"Malone RS","year":"1999","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref46","series-title":"Gu\u00eda de la Tuberculosis para M\u00e9dicos Especialistas","author":"Caminero Luna JA","year":"2003"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.47.12.3799-3805.2003","article-title":"ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates","volume":"47","author":"Morlock GP","year":"2003","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ccm.2009.08.015","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis in the West: Europe and United States: epidemiology, surveillance, and control","volume":"30","author":"Migliori GB","year":"2009","journal-title":"Clin Chest Med","ISSN":"https:\/\/id.crossref.org\/issn\/0272-5231","issn-type":"print"},{"issue":"2","key":"ref49","first-page":"106","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/thorax.56.6.494","article-title":"Tuberculosis in pregnancy and the puerperium","volume":"56","author":"Ormerod P","year":"2001","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/374225","article-title":"Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases","volume":"36","author":"Shin S","year":"2003","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"2","key":"ref52","first-page":"89","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"key":"ref53","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"533","volume-title":"Antimycobacterial agents","author":"Wallace Jr RC","year":"2009"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1472-9792(08)70019-2","article-title":"Para-aminosalicylic acid","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"key":"ref55","series-title":"Goodman & Gilman: As Bases Farmacol\u00f3gicas da Terap\u00eautica","first-page":"1083","volume-title":"Quimioterapia da tuberculose, complexo mycobacterium avium e hansen\u00edase","author":"Petri Jr WA","year":"2006"},{"issue":"15","key":"ref56","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis","volume":"62","author":"Peloquin CA","year":"2002","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1590\/S1806-37132004000700003","article-title":"Tuberculose: Guia de vigil\u00e2ncia epidemiol\u00f3gica","volume":"30","author":"Silva Jr JB","year":"2004","journal-title":"J Bras Pneumol"},{"key":"ref58","series-title":"Controle da tuberculose: uma proposta de integra\u00e7\u00e3o ensino-servi\u00e7o","year":"2002"},{"key":"ref59","series-title":"Treatment of Tuberculosis: Guidelines","year":"2009","edition":"4"},{"key":"ref60","first-page":"52","article-title":"Rea\u00e7\u00f5es adversas das drogas tuberculost\u00e1ticas","volume":"19","author":"Morrone N","year":"1993","journal-title":"J Pneumol","ISSN":"https:\/\/id.crossref.org\/issn\/0102-3586","issn-type":"print"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v36n5\/v36n5a17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T07:58:44Z","timestamp":1559807924000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132010000500017&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1806-37132010000500017"],"URL":"https:\/\/doi.org\/10.1590\/s1806-37132010000500017","relation":{},"ISSN":["1806-3713"],"issn-type":[{"value":"1806-3713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}